Manufacturers race toward the $1000 genome

Thanks to a steady stream of technology advances, the cost of DNA sequencing has plummeted in recent years. When it was first accomplished in 2001, the cost of sequencing the human genome was estimated at $3 billion, and it took more than a decade to complete with the traditional Sanger sequencing approach and automated capillary-based sequencing instruments.1 While this was a phenomenal achievement with broad implications, it was clearly a long way from being a practical technique for disease diagnosis or drug development.

Today, many dream of being able to routinely sequence a person's entire genome for just $1000 in a matter of weeks or even days. Researchers and healthcare professionals alike believe that achieving this goal would "democratize" DNA sequencing and bring with it the anticipated health benefits of knowing someone's complete genetic makeup and the associated risks of disease and drug susceptibilities (see "$1000 genome disease scans now available to the public," p. 36).

The path to the $1000 genome and a possible new era of predictive and preventive medicine is being paved by the introduction of some dramatic new DNA sequencing technologies—notably massively parallel next-generation sequencing instruments. In fact, in 2007 the genome of Nobel Laureate James Watson—codiscoverer of the DNA double helix and father of the Human Genome Project—was sequenced in just two months at a cost of $2 million to $3 million using a massively parallel sequencing system.2

Editors Note: To read the full article, click here.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

NANOTECHNOLOGY/LIGHT ACTIVATION: IR light method turns blood clotting on (like drugs) and off (like nothing else)

Gold nanoparticles, controlled by infrared (IR) light from a pulsed femtosecond laser, promise to promote wound healing and help doctors control blood clotting in patients undergoing surgery.

Microscopy helps discover potential new drug target for cystic fibrosis

An international team of scientists, using automated microscopy and genetics, have discovered a promising potential drug target for cystic fibrosis.

Next-gen DNA sequencing helps provide new genetic clue to anorexia

The largest next-generation DNA sequencing study of anorexia nervosa to date has linked the eating disorder to variants in a gene coding for an enzyme that regulates cholesterol metabolism.

Synchrotron light identifies RNA double helix structure

Scientists at McGill University have crystallized a short RNA sequence, poly (rA)11, and used data collected at the Canadian Light Source (CLS) and the Cornell High Energy Synchrotron to confirm th...


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World